Top Markets
#1 Akedo Akedo +58.47%
#2 Glidr Glidr +51.75%
#3 DOVU DOVU +50.71%
#4 Cross Cross +45.85%
#5 Black Phoenix Black Phoenix +34.29%
#6 Velvet Velvet +30.75%
#7 OVERTAKE OVERTAKE +19.61%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +16.83%
#9 Cap Cap +15.18%
#10 QANplatform QANplatform +14.92%
Coin of the day
Akedo Akedo
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Lipidor AB (publ) Lipidor AB (publ)

Lipidor AB (publ)

LIPI
Rangering i aksjer #39103
Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in... Lipidor AB (publ), a Swedish pharmaceutical company founded in Danderyd in 2009, specializes in developing medicinal products. Its core business centers on creating treatments for various skin conditions, including psoriasis, bacterial skin infections, and atopic dermatitis. The company's product pipeline includes AKP-01, which is currently in Phase III clinical trials for psoriasis, while other formulations like AKP-02 (also for psoriasis) and AKP-03 and AKP-07 (for eczema) are in earlier, preclinical development stages. Beyond its own drug candidates, Lipidor manufactures and supplies active pharmaceutical ingredients (APIs). These APIs are incorporated into products addressing a broad spectrum of therapeutic applications, such as managing psoriasis, microbial infections, inflammation, fungal issues, local pain relief, acne, wound healing, eczema, and migraines. Lipidor also caters to the animal health market, offering a line of spray-on skin care products for dogs, cats, and horses. Additionally, it develops consumer health items designed for purposes like antibacterial action, antiseptic care, moisturizing, disinfection, and treating acne and warts. In a key strategic alliance, Lipidor has partnered with Cannassure Therapeutics Ltd. This collaboration aims to advance topical medicinal cannabis products specifically formulated to alleviate skin inflammations and psoriatic lesions.
Aksjekurs
$0.02243487
Sist synkronisert: 2025-06-04
Markedsverdi
$650.09K
Endring (1 dag)
0.39%
Endring (1 år)
0.00%
Land
SE
Handel Lipidor AB (publ) (LIPI)

Kategori

Healthcare
Driftsmargin for Lipidor AB (publ) (LIPI)
Driftsmargin per August 2026 TTM: -101,500.00%
Ifølge Lipidor AB (publ) sine siste økonomiske rapporter og aksjekurs er selskapets nåværende driftsmargin (TTM) -101,500.00%. Ved slutten av 2023 hadde selskapet en driftsmargin på -19,812.82%.
Historikk for driftsmargin for Lipidor AB (publ) fra 2016 til 2026
Driftsmargin ved slutten av hvert år
År Driftsmargin Endre
2026 (TTM) -101,500.00% 0.00%
2024 -101,500.00% 412.29%
2023 -19,812.82% -78.50%
2022 -92,155.56% 66,165.59%
2021 -139.07% -94.70%
2020 -2,623.23% -86.32%
2019 -19,177.78% 510.45%
2018 -3,141.56% 240.80%
2017 -921.82% -46.73%
2016 -1,730.46% 0.00%
Driftsmargin for lignende selskaper eller konkurrenter
Selskap Driftsmargin Forskjell i driftsmargin Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
45.87% -100.00%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
26.81% -100.00%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
27.60% -100.00%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
26.59% -100.00%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
27.59% -100.00%
US
Hva er selskapets Driftsmargin?
Driftsmargin er en nøkkelindikator for å vurdere lønnsomheten til et selskap. Høyere Driftsmargins er vanligvis bedre, da de viser at selskapet kan selge sine produkter eller tjenester for mye mer enn produksjonskostnadene. Driftsmargin beregnes ved å dele selskapets inntjening med inntektene.